市場調查報告書
商品編碼
1451782
2024-2032 年按產品類型、技術、應用、最終用戶和地區分類的植入式給藥裝置市場報告Implantable Drug Delivery Devices Market Report by Product Type, Technology, Application, End User, and Region 2024-2032 |
2023年全球植入式給藥裝置市場規模達143億美元。展望未來, IMARC Group預計到2032年市場規模將達到263億美元,2024-2032年複合年成長率(CAGR)為6.81%。慢性病盛行率不斷上升、對微創手術的需求不斷成長、易患慢性疾病的老年人口不斷增加,以及植入設備技術的快速進步是推動市場的一些關鍵因素。
植入式藥物輸送裝置被植入體內,以便能夠在較長時間內持續釋放藥物。這些設備的構造涉及幾個關鍵組件,包括儲庫或含有藥物的隔間、釋放機構以及用於監測藥物水平或生理參數並提供即時反饋的感測器。與傳統的給藥方法相比,植入式藥物傳遞裝置具有許多優點,例如維持血流中恆定的藥物濃度並避免與口服藥物相關的高峰和低谷。這確保了最佳的治療水平並提高了患者的依從性。此外,這些設備可以編程為在特定的時間間隔釋放藥物,從而減少頻繁給藥的需要並提高患者的便利性。此外,植入式藥物輸送裝置可實現局部藥物輸送,最大限度地減少全身副作用並提高治療效果。目前,有多種類型的植入式藥物輸送裝置,包括植入式泵,它利用電機驅動機構以受控的速率將藥物從儲庫中推出。
全球植入式給藥裝置市場的成長主要受到多種因素的推動,包括癌症、糖尿病和心血管疾病等慢性病盛行率的不斷上升。此外,對微創手術的需求不斷成長,以及更容易患慢性疾病的老年人口不斷增加,正在推動市場成長。此外,植入式設備的快速技術進步(例如可生物分解和可編程藥物傳輸系統的開發)以及對長期治療解決方案不斷成長的需求正在推動市場成長。除此之外,降低醫療成本的需求不斷成長以及有利的報銷政策的提供正在推動市場的成長。據此,各國政府正在採取措施推廣先進的醫療保健技術,這反過來又推動了市場的成長。旨在推出新穎和創新的植入式藥物輸送設備的新興研發(R&D)活動也正在推動市場擴張。其他因素,例如人們對植入式藥物輸送裝置的好處的認知不斷增強,以及對個人化醫療和標靶藥物輸送的日益關注,也促進了市場的成長。
The global implantable drug delivery devices market size reached US$ 14.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 26.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.81% during 2024-2032. The increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, the growing geriatric population susceptible to chronic disorders, and rapid technological advancements in implantable devices are some of the key factors driving the market.
Implantable drug delivery devices are implanted within the body to enable the sustained release of drugs over an extended period. The construction of these devices involves several key components, including a reservoir or a drug-containing compartment, a release mechanism, and sensors to monitor drug levels or physiological parameters, providing real-time feedback. Implantable drug delivery devices offer numerous advantages over conventional drug administration methods, such as maintaining a constant drug concentration in the bloodstream and avoiding the peaks and troughs associated with oral medications. This ensures optimal therapeutic levels and improves patient compliance. Furthermore, these devices can be programmed to release drugs at specific intervals, reducing the need for frequent dosing and improving convenience for patients. Additionally, implantable drug delivery devices enable localized drug delivery, minimizing systemic side effects and enhancing the efficacy of treatment. Currently, there are various types of implantable drug delivery devices available, including implantable pump, which utilizes a motor-driven mechanism to push the drug out of the reservoir at a controlled rate.
The global implantable drug delivery devices market is primarily accelerated by various factors, including the escalating prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders. Moreover, the rising demand for minimally invasive procedures and the growing geriatric population, which is more susceptible to chronic illnesses, are driving the market growth. Additionally, rapid technological advancements in implantable devices, such as the development of biodegradable and programmable drug delivery systems, and the escalating demand for long-term therapeutic solutions are fueling the market growth. Besides this, the escalating need to reduce healthcare costs and the availability of favorable reimbursement policies are bolstering the market growth. In line with this, governments of various nations are undertaking initiatives to promote advanced healthcare technologies, which, in turn, is propelling the market growth. The burgeoning research and development (R&D) activities aimed at introducing novel and innovative implantable drug delivery devices are also driving market expansion. Other factors, such as the growing awareness about the benefits of implantable drug delivery devices and enhancing focus on personalized medicine and targeted drug delivery, are contributing to the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global implantable drug delivery devices market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, technology, application, and end user.
Implantable Drug Eluting Stents
Implantable Contraceptive Drug Delivery Devices
Implantable Intraocular Drug Delivery Devices
Implantable Brachytherapy Seeds Devices
Implantable Drug Delivery Pump Devices
The report has provided a detailed breakup and analysis of the implantable drug delivery devices market based on the product type. This includes implantable drug eluting stents, implantable contraceptive drug delivery devices, implantable intraocular drug delivery devices, implantable brachytherapy seeds devices, and implantable drug delivery pump devices. According to the report, implantable drug eluting stents represented the largest segment.
Biodegradable Implants
Non-Biodegradable Implants
A detailed breakup and analysis of the implantable drug delivery devices market based on technology has also been provided in the report. This includes biodegradable and non-biodegradable implants. According to the report, non-biodegradable implants accounted for the largest market share.
Oncology
Cardiovascular
Autoimmune Diseases
Obstetrics and Gynecology
Others
The report has provided a detailed breakup and analysis of the implantable drug delivery devices market based on the application. This includes oncology, cardiovascular, autoimmune diseases, obstetrics and gynecology, and others. According to the report, cardiovascular represented the largest segment.
Hospitals
Ambulatory Surgery Centers
Others
A detailed breakup and analysis of the implantable drug delivery devices market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgery centers, and others. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for implantable drug delivery devices. Some of the factors driving the North America implantable drug delivery devices market included the expanding pharmaceutical industry, the emergence of new drug delivery techniques, the availability of skilled healthcare professionals, and the establishment of specialized clinics and hospitals.
The report has also provided a comprehensive analysis of the competitive landscape in the global implantable drug delivery devices market. Detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Boston Scientific Corporation, Delpor Inc., Koninklijke DSM N.V., Medtronic plc, Theragenics Corporation, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.